TrueLok Elevate Bone Transport Study for Chronic Foot Ulcers

This important clinical study evaluates the effectiveness of the TrueLok Elevate Transverse Bone Transport System for treating chronic foot ulcers that haven't responded to standard treatments. The device offers new hope for patients struggling with persistent wounds that won't heal.

The study will follow 153 adult patients with chronic lower limb ulcers that have lasted at least 3 months despite various treatments like wound debridement, vacuum therapy, antibiotics, or vascular optimization. Researchers want to see how many patients achieve complete wound healing within 12 months after device removal.

Chronic wounds significantly impact quality of life, often causing pain, mobility issues, and emotional distress. For diabetic patients especially, foot ulcers can lead to serious complications if not properly treated. This research is crucial because it explores an innovative surgical approach when conventional treatments fail.

Participants must be 18 years or older and willing to follow study requirements. The study excludes patients with certain health conditions that might affect healing or their ability to participate fully. All participants will need to attend follow-up visits so researchers can monitor their progress.

Key aspects of the study include:

• Tracking complete ulcer healing (full skin closure)
• Monitoring patients for 12 months after treatment
• Assessing the safety and performance of the TrueLok Elevate system

This research matters because chronic wounds represent a major healthcare challenge, particularly for aging populations and people with diabetes. Successful new treatments could reduce hospital visits, prevent amputations, and improve daily life for many patients. The study will provide valuable real-world data about this specialized bone transport technique.

For caregivers, understanding treatment options is vital when supporting loved ones with chronic wounds. Studies like this help medical teams determine which interventions work best for stubborn ulcers that resist standard care. The findings may lead to more effective protocols for wound management nationwide.

While the study focuses on a specific device, its results could advance overall wound care knowledge. Researchers will examine not just whether wounds heal, but how the healing process occurs with this method. This information could benefit future patients even if they receive different treatments.

If you or someone you care for suffers from chronic foot ulcers, discussing this research with a healthcare provider might help determine if similar treatments could be appropriate. Always consult medical professionals about participating in clinical studies or trying new therapies.